Abstract
Diabetic nephropathy (DN) is the leading cause of uremia and clinical mortality, characterized by the progressive deterioration of kidney structure and function due to prolonged exposure to hyperglycemia. This condition often necessitates renal replacement therapy for patients with end-stage-renal-disease (ESRD). Consequently, early detection, diagnosis, and treatment of DN are crucial to mitigate disease progression, enhance patient outcomes, and maintain a good quality of life. Exploring relevant biomarkers for the early diagnosis of DN holds significant importance. In recent years, numerous researchers have identified various novel biomarkers associated with diabetic nephropathy, which are critical for predicting both the onset and progression of the disease. This article aims to provide a comprehensive overview of the biomarkers related to DN.
Funding Information
  • National Natural Science Foundation of China (81473427)
  • Xinglin Talent Program of Chengdu University of Traditional Chinese Medicine (QJJJ2023017)
  • Sichuan Provincial Science and Technology Program (2021YJ0112)
  • Scientific Research Project of Sichuan Provincial Administration of Traditional Chinese Medicine (2024MS046)

This publication has 142 references indexed in Scilit: